Table 1.
Clinical characteristic
| Clinical information | Group I(81) | Group II (44) | P-value |
|---|---|---|---|
| General information | |||
| Sex (female/male) | 36/45 | 22/22 | 0.552 |
| Age, years | 6.54 ± 3.03 | 7.61 ± 2.49 | 0.031 |
| Weight, kg | 20.4 (16.4, 28.9) | 27.2 (20.0, 33.5) | 0.002 |
| Clinical presentation n (%) | |||
| Fever | 81 (100%) | 44 (100%) | 1.00 |
| Cough | 75 (92.6%) | 43 (97.7%) | 0.891 |
| Hypoxemia | 6 (7.41%) | 28 (63.6%) | 0.000 |
| respiratory failure | 0 | 2 (4.55%) | 0.041 |
| Extra-pulmonary complications | 18 (22.2%) | 33 (75.0%) | 0.007 |
| Thromboembolism | 2 (2.47%) | 2 (4.55%) | 0.613 |
| total fever duration, days | 11 (8, 13) | 13 (11, 15) | 0.000 |
| preadmission fever duration, days | 7 (5, 8) | 6 (4, 7) | 0.329 |
| fever duration at the time of CS treatmenta, days | 1.95 ± 1.91 | 5.45 ± 2.76 | 0.000 |
| Length of stay, days | 8 (7, 10) | 13.5 (11.3, 16) | 0.000 |
| Management | |||
| Hormone dose, mg/kg/day | 2 (1.5, 2) | 10 (8.5, 10) | 0.000 |
| Gamma globulin, n (%) | 9 (11.1%) | 17 (38.6%) | 0.000 |
| Bronchoscopy, n (%) | 57 (70.4%) | 41 (93.2%) | 0.000 |
| Plastic bronchitis, n (%) | 14 (17.3%) | 29 (65.9%) | 0.000 |
Data are presented as number (percentage), median (25th–75th percentile). Data are presented as mean ± SD (x ± s)
aThe meaning of fever duration at the time of corticosteroids treatment is that fever days after starting corticosteroids therapy